Surgery Partners PE Ratio 2013-2024 | SGRY
Current and historical p/e ratio for Surgery Partners (SGRY) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Surgery Partners PE ratio as of April 01, 2025 is 34.93.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Surgery Partners PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-03-31 | 23.75 | 0.00 | |
| 2024-12-31 | 21.17 | $-1.33 | 0.00 |
| 2024-09-30 | 32.24 | $-0.48 | 0.00 |
| 2024-06-30 | 23.79 | $-0.27 | 0.00 |
| 2024-03-31 | 29.83 | $-0.00 | 0.00 |
| 2023-12-31 | 31.99 | $-0.10 | 0.00 |
| 2023-09-30 | 29.25 | $-0.32 | 0.00 |
| 2023-06-30 | 44.99 | $-0.56 | 0.00 |
| 2023-03-31 | 34.47 | $-0.92 | 0.00 |
| 2022-12-31 | 27.86 | $-0.58 | 0.00 |
| 2022-09-30 | 23.40 | $-0.35 | 0.00 |
| 2022-06-30 | 28.92 | $-0.35 | 0.00 |
| 2022-03-31 | 55.05 | $-0.53 | 0.00 |
| 2021-12-31 | 53.41 | $-1.24 | 0.00 |
| 2021-09-30 | 42.34 | $-1.34 | 0.00 |
| 2021-06-30 | 66.62 | $-2.52 | 0.00 |
| 2021-03-31 | 44.26 | $-2.99 | 0.00 |
| 2020-12-31 | 29.01 | $-3.18 | 0.00 |
| 2020-09-30 | 21.90 | $-3.65 | 0.00 |
| 2020-06-30 | 11.57 | $-2.70 | 0.00 |
| 2020-03-31 | 6.53 | $-2.43 | 0.00 |
| 2019-12-31 | 15.66 | $-2.27 | 0.00 |
| 2019-09-30 | 7.39 | $-4.95 | 0.00 |
| 2019-06-30 | 8.14 | $-5.05 | 0.00 |
| 2019-03-31 | 11.28 | $-5.03 | 0.00 |
| 2018-12-31 | 9.79 | $-4.96 | 0.00 |
| 2018-09-30 | 16.50 | $-2.54 | 0.00 |
| 2018-06-30 | 14.90 | $-2.59 | 0.00 |
| 2018-03-31 | 17.15 | $-2.11 | 0.00 |
| 2017-12-31 | 12.10 | $-1.64 | 0.00 |
| 2017-09-30 | 10.35 | $-0.46 | 0.00 |
| 2017-06-30 | 22.75 | $0.15 | 151.67 |
| 2017-03-31 | 19.50 | $0.28 | 69.64 |
| 2016-12-31 | 15.85 | $0.19 | 83.42 |
| 2016-09-30 | 20.24 | $0.19 | 106.53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.031B | $3.114B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.516B | 27.37 |
| Elevance Health (ELV) | United States | $98.469B | 13.19 |
| CVS Health (CVS) | United States | $85.419B | 12.50 |
| Cencora (COR) | United States | $53.926B | 19.57 |
| DiDi Global (DIDIY) | China | $23.525B | 0.00 |
| Natera (NTRA) | United States | $19.117B | 0.00 |
| BioMerieux (BMXMF) | France | $14.914B | 0.00 |
| ICON (ICLR) | Ireland | $14.132B | 12.84 |
| Solventum (SOLV) | United States | $13.154B | 12.27 |
| Revvity (RVTY) | United States | $12.712B | 21.59 |
| Avantor (AVTR) | United States | $11.045B | 16.21 |
| CochLear (CHEOY) | Australia | $10.877B | 0.00 |
| Doximity (DOCS) | United States | $10.834B | 56.34 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.609B | 0.00 |
| Viatris (VTRS) | United States | $10.397B | 3.29 |
| Medpace Holdings (MEDP) | United States | $9.283B | 24.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.768B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.697B | 14.59 |
| HealthEquity (HQY) | United States | $7.644B | 37.60 |
| Bausch + Lomb (BLCO) | Canada | $5.111B | 23.39 |
| Amplifon S.p.A (AMFPF) | Italy | $4.961B | 26.19 |
| Organon (OGN) | United States | $3.841B | 3.91 |
| Alignment Healthcare (ALHC) | United States | $3.572B | 0.00 |
| Sotera Health (SHC) | United States | $3.305B | 19.11 |
| BrightSpring Health Services (BTSG) | United States | $3.165B | 32.89 |
| Concentras Parent (CON) | United States | $2.781B | 14.47 |
| GeneDx Holdings (WGS) | United States | $2.486B | 295.22 |
| Ardent Health Partners (ARDT) | United States | $1.963B | 0.00 |
| Progyny (PGNY) | United States | $1.908B | 42.15 |
| Agilon Health (AGL) | United States | $1.785B | 0.00 |
| Premier (PINC) | United States | $1.760B | 11.27 |
| PACS (PACS) | United States | $1.713B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.692B | 36.75 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.243B | 10.42 |
| Establishment Labs Holdings (ESTA) | $1.177B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.031B | 0.00 |
| CareDx (CDNA) | United States | $0.984B | 16.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.934B | 7.39 |
| Embecta (EMBC) | United States | $0.741B | 5.08 |
| QDM (QDMI) | Hong Kong, SAR China | $0.526B | 13.77 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 13.94 |
| Enhabit (EHAB) | United States | $0.444B | 41.86 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.269B | 11.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.265B | 0.00 |
| Nutex Health (NUTX) | United States | $0.256B | 5.10 |
| LifeMD (LFMD) | United States | $0.243B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.168B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| So-Young (SY) | China | $0.098B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.056B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.57 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |